Meta-analysis of carvedilol versus beta 1 selective beta-blockers (atenolol, bisoprolol, metoprolol, and nebivolol)

American Journal of Cardiology

Volumn 111, Issue 5, 2013, Pages 765-769

  Dinicolantonio, James J ^a   Lavie, Carl J ^b,c   Fares, Hassan ^b   Menezes, Arthur R ^b   O'Keefe, James H ^d  

^a Wegmans Pharmacy   (United States)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^d UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; BISOPROLOL; CARVEDILOL; METOPROLOL; NEBIVOLOL;

ACUTE HEART INFARCTION; CARDIOVASCULAR MORTALITY; CORONARY ARTERY DISEASE; DRUG EFFECT; FOLLOW UP; HOSPITAL READMISSION; HUMAN; MEDLINE; META ANALYSIS; MORBIDITY; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; SYSTOLIC HEART FAILURE; THERAPY EFFECT;

EID: 84873734025     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2012.11.031     Document Type: Article

References (29)

1. P.O. Vandvik, A.M. Lincoff, J.M. Gore, D.D. Gutterman, F.A. Sonnenberg, P. Alonso-Coello, E.A. Akl, M.G. Lansberg, G.H. Guyatt, and F.A. Spencer Primary and secondary prevention of cardiovascular disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Chest 141 2012 e637S e668S
2. M. Jessup, W.T. Abraham, D.E. Casey, A.M. Feldman, G.S. Francis, T.G. Ganiats, M.A. Konstam, D.M. Mancini, P.S. Rahko, M.A. Silver, L.W. Stevenson, and C.W. Yancy 2009 focused update: ACCF/AHA guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation Circulation 119 2009 1977 2016
3. P.A. Poole-Wilson, K. Swedberg, J.G. Cleland, A. Di Lenarda, P. Hanrath, M. Komajda, J. Lubsen, B. Lutiger, M. Metra, W.J. Remme, C. Torp-Pedersen, A. Scherhag, and A. Skene Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol or Metoprolol European Trial (COMET): randomised controlled trial Lancet 362 2003 7 13
4. A. Liberati, D.G. Altman, J. Tetzlaff, C. Mulrow, P.C. Gotzsche, J.P. Ioannidis, M. Clarke, P.J. Devereaux, J. Kleijnen, and D. Moher The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration BMJ 339 2009 b2700
5. A.R. Jadad, R.A. Moore, D. Carroll, C. Jenkinson, D.J. Reynolds, D.J. Gavaghan, and H.J. McQuay Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17 1996 1 12
6. J.P. Higgins, and S.G. Thompson Quantifying heterogeneity in a meta-analysis Stat Med 21 2002 1539 1558
7. J.P. Higgins, and S. Green Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 2008 John Wiley Hoboken, New Jersey 633
8. I.B. Mrdovic, L.Z. Savic, J.P. Perunicic, M.R. Asanin, R.M. Lasica, M.M. Jelena, M.D. Matic, Z.M. Vasiljevic, and M.C. Ostojic Randomized active-controlled study comparing effects of treatment with carvedilol versus metoprolol in patients with left ventricular dysfunction after acute myocardial infarction Am Heart J 154 2007 116 122
9. G. Jonsson, M. Abdelnoor, C. Muller, S.E. Kjeldsen, I. Os, and A. Westheim A comparison of the two beta-blockers carvedilol and atenolol on left ventricular ejection fraction and clinical endpoints after myocardial infarction. a single-centre, randomized study of 232 patients Cardiology 103 2005 148 155
10. G. Marazzi, M. Volterrani, G. Caminiti, L. Iaia, R. Massaro, C. Vitale, B. Sposato, G. Mercuro, and G. Rosano Comparative long term effects of nebivolol and carvedilol in hypertensive heart failure patients J Card Fail 17 2011 703 709
11. N. Aygul, K. Ozdemir, M.A. Duzenli, and M.U. Aygul The comparative effects of long-term carvedilol versus bisoprolol therapy on QT dispersion in patients with chronic heart failure Cardiology 112 2009 168 173
12. H.D. Dungen, S. Apostolovic, S. Inkrot, E. Tahirovic, A. Topper, F. Mehrhof, C. Prettin, B. Putnikovic, A.N. Neskovic, M. Krotin, D. Sakac, M. Lainscak, F. Edelmann, R. Wachter, T. Rau, T. Eschenhagen, W. Doehner, S.D. Anker, F. Waagstein, C. Herrmann-Lingen, G. Gelbrich, and R. Dietz Titration to target dose of bisoprolol vs. carvedilol in elderly patients with heart failure: the CIBIS-ELD trial Eur J Heart Fail 13 2011 670 680
13. M. Metra, R. Giubbini, S. Nodari, E. Boldi, M.G. Modena, and L. Dei Cas Differential effects of beta-blockers in patients with heart failure: a prospective, randomized, double-blind comparison of the long-term effects of metoprolol versus carvedilol Circulation 102 2000 546 551
14. M.L. Kukin, J. Kalman, R.H. Charney, D.K. Levy, C. Buchholz-Varley, O.N. Ocampo, and C. Eng Prospective, randomized comparison of effect of long-term treatment with metoprolol or carvedilol on symptoms, exercise, ejection fraction, and oxidative stress in heart failure Circulation 99 1999 2645 2651
15. G. Piccirillo, R. Quaglione, M. Nocco, C. Naso, A. Moise, M. Lionetti, S. Di Carlo, and V. Marigliano Effects of long-term beta-blocker (metoprolol or carvedilol) therapy on QT variability in subjects with chronic heart failure secondary to ischemic cardiomyopathy Am J Cardiol 90 2002 1113 1117
16. R. Tolg, M. Witt, B. Schwarz, T. Kurz, V. Kurowski, F. Hartmann, V. Geist, and G. Richardt Comparison of carvedilol and metoprolol in patients with acute myocardial infarction undergoing primary coronary intervention - the PASSAT study Clin Res Cardiol 95 2006 31 41
17. R.M. Lombardo, C. Reina, M.G. Abrignani, P.A. Rizzo, A. Braschi, and S. De Castro Effects of nebivolol versus carvedilol on left ventricular function in patients with chronic heart failure and reduced left ventricular systolic function Am J Cardiovasc Drugs 6 2006 259 263
18. S. Acikel, H. Bozbas, B. Gultekin, A. Aydinalp, B. Saritas, U. Bal, A. Yildirir, H. Muderrisoglu, A. Sezgin, and B. Ozin Comparison of the efficacy of metoprolol and carvedilol for preventing atrial fibrillation after coronary bypass surgery Int J Cardiol 126 2008 108 113
19. M. Haghjoo, M. Saravi, M.J. Hashemi, S. Hosseini, N. Givtaj, M.H. Ghafarinejad, A.J. Khamoushi, Z. Emkanjoo, A.F. Fazelifar, A. Alizadeh, and M.A. Sadr-Ameli Optimal beta-blocker for prevention of atrial fibrillation after on-pump coronary artery bypass graft surgery: carvedilol versus metoprolol Heart Rhythm 4 2007 1170 1174
20. H.J. Dargie Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial Lancet 357 2001 1385 1390
21. C. Torp-Pedersen, P.A. Poole-Wilson, K. Swedberg, J.G. Cleland, A. Di Lenarda, P. Hanrath, M. Komajda, B. Lutiger, M. Metra, W.J. Remme, A. Scherhag, and A. Skene Effects of metoprolol and carvedilol on cause-specific mortality and morbidity in patients with chronic heart failure - COMET Am Heart J 149 2005 370 376
22. M. Packer, G.V. Antonopoulos, J.A. Berlin, J. Chittams, M.A. Konstam, and J.E. Udelson Comparative effects of carvedilol and metoprolol on left ventricular ejection fraction in heart failure: results of a meta-analysis Am Heart J 141 2001 899 907
23. V.O. Nikolaev, A. Moshkov, A.R. Lyon, M. Miragoli, P. Novak, H. Paur, M.J. Lohse, Y.E. Korchev, S.E. Harding, and J. Gorelik Beta2-adrenergic receptor redistribution in heart failure changes cAMP compartmentation Science 327 2010 1653 1657
24. S.Y. Martsevich, N.P. Kutishenko, A.D. Deev, R.G. Oganov, and S.A. Shalnova Comparison of antihypertensive and metabolic effects of carvedilol and metaprolol in hypertensive patients with overweight and obesity. Camellia Trial J Hyper 28 2010 e560
25. G.L. Bakris, V. Fonseca, R.E. Katholi, J.B. McGill, F.H. Messerli, R.A. Phillips, P. Raskin, J.T. Wright Jr., R. Oakes, M.A. Lukas, K.M. Anderson, and D.S. Bell Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial JAMA 292 2004 2227 2236
26. E.M. Gilbert, W.T. Abraham, S. Olsen, B. Hattler, M. White, P. Mealy, P. Larrabee, and M.R. Bristow Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart Circulation 94 1996 2817 2825
27. S. Morimoto, K. Shimizu, K. Yamada, S. Hiramitsu, and H. Hishida Can beta-blocker therapy be withdrawn from patients with dilated cardiomyopathy? Am Heart J 138 1999 456 459
28. I. Aursnes, J.B. Osnes, I.F. Tvete, J. Gasemyr, and B. Natvig Does atenolol differ from other beta-adrenergic blockers? BMC Clin Pharmacol 7 2007 4
29. B. Carlberg, O. Samuelsson, and L.H. Lindholm Atenolol in hypertension: is it a wise choice? Lancet 364 2004 1684 1689